Fig. 2
Expression levels and prognostic values of KDM5C and PFDN5 in CRC patients. A, B IHC assay to detect the protein levels of KDM5C A and PFDN5 B in CRC tissues and the adjacent normal tissues; C, D RT-qPCR to detect the mRNA levels of KDM5C C and PFDN5 D in CRC tissues and the adjacent normal tissues (n = 72) (paired t test); E, a negative correlation between KDM5C and PFDN5 mRNA expression in CRC tissues (n = 72) (Pearson's correlation analysis); F–G, correlations of KDM5C F and PFDN5 G expression with the RFS of patients (Log-rank (Mantel-Cox) test). *p < 0.05